EV/EBITDA
-7.47
-0.26-3.61%
0 min ago
Summary
- As of March 12, 2025, NAMS EV/EBITDA is -7.47, with a fall of -0.26 (-3.61%) during the most recent trading day.
- Over the past year, NAMS EV/EBITDA has increased by +2.22 (+22.91%).
- NAMS EV/EBITDA is now -127.74% below its all-time high of -3.28.
Performance
NAMS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NAMS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -3.6% | +3.7% | +2.5% |
| 1 m1 month | -31.8% | +31.7% | +18.4% |
| 3 m3 months | +27.2% | -2.6% | -4.8% |
| 6 m6 months | -46.5% | +72.4% | +42.9% |
| ytdytd | +10.1% | -10.0% | -8.7% |
| 1 y1 year | +22.9% | +5.3% | +2.0% |
| 5 y5 years | - | - | - |
NAMS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -66.4% | -7.66 | +2.5% | |
| 3 m | 3-month | -4.49 | -66.4% | -13.39 | +44.2% |
| 6 m | 6-month | -4.49 | -66.4% | -13.39 | +44.2% |
| 1 y | 1-year | -4.49 | -66.4% | -13.39 | +44.2% |
| 3 y | 3-year | -3.28 | -127.7% | -13.39 | +44.2% |
| 5 y | 5-year | -3.28 | -127.7% | -13.39 | +44.2% |
| alltime | all time | -3.28 | -127.7% | -13.39 | +44.2% |
NewAmsterdam Pharma Company NV EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.47(-10.1%) |
| Date | Value |
|---|---|
| 2024 | -8.31(+153.4%) |
| 2023 | -3.28 |
FAQ
- What is NewAmsterdam Pharma Company NV EV/EBITDA?
- What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV?
- What is NAMS EV/EBITDA year-to-date change?
- What is NewAmsterdam Pharma Company NV EV/EBITDA year-on-year change?
What is NewAmsterdam Pharma Company NV EV/EBITDA?
The current EV/EBITDA of NAMS is -7.47
What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high EV/EBITDA is -3.28
What is NAMS EV/EBITDA year-to-date change?
NewAmsterdam Pharma Company NV EV/EBITDA has changed by +0.84 (+10.11%) since the beginning of the year
What is NewAmsterdam Pharma Company NV EV/EBITDA year-on-year change?
Over the past year, NAMS EV/EBITDA has changed by +2.22 (+22.91%)